Covid-19 Impact on Global Active Pharmaceutical Ingredients (API) Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 24-Apr-2020
No. of pages: 150
Inquire Before Buying

An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.

The EMEA average price of Active Pharmaceutical Ingredients is in the decreasing trend, from 6695 USD/MT in 2012 to 5483 USD/MT in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Active Pharmaceutical Ingredients (API) 3900 market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Active Pharmaceutical Ingredients (API) 3900 industry.

Based on our recent survey, we have several different scenarios about the Active Pharmaceutical Ingredients (API) 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 63210 million in 2019. The market size of Active Pharmaceutical Ingredients (API) 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Active Pharmaceutical Ingredients (API) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Active Pharmaceutical Ingredients (API) market in terms of both revenue and volume.

Players, stakeholders, and other participants in the global Active Pharmaceutical Ingredients (API) market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Sales and Pricing Analyses

Readers are provided with deeper sales analysis and pricing analysis for the global Active Pharmaceutical Ingredients (API) market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.

In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Active Pharmaceutical Ingredients (API) market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Active Pharmaceutical Ingredients (API) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Active Pharmaceutical Ingredients (API) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Active Pharmaceutical Ingredients (API) market.

The following manufacturers are covered in this report:

- Teva

- Mylan

- DSM

- Aurobindo Pharma

- Aspen

- Novartis

- BASF

- Pfizer

- Huahai Pharmaceutical

- Hisun Pharmaceutical

- Sun Pharmaceutical Industries

- Zhejiang Medicine

- Dr. Reddy's Laboratories

- Zhejiang NHU

- Bayer

- NCPC

- AbbVie

- Shandong Xinhua Pharmaceutical

- Northeast Pharm

- Harbin Pharmaceutical

- LKPC

Active Pharmaceutical Ingredients (API) Breakdown Data by Type

- Synthetic APIs

- Biotech APIs

Active Pharmaceutical Ingredients (API) Breakdown Data by Application

- CNS

- Cardiovascular

- Genitourinary/Hormonal Drugs

- Respiratory

- Rheumatology

- Diabetes

- Oncology

- Others

Covid-19 Impact on Global Active Pharmaceutical Ingredients (API) Market Size, Status and Forecast 2020-2026

Table of Contents
1 Study Coverage
1.1 Active Pharmaceutical Ingredients (API) Product Introduction
1.2 Market Segments
1.3 Key Active Pharmaceutical Ingredients (API) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Type
1.4.2 Synthetic APIs
1.4.3 Biotech APIs
1.5 Market by Application
1.5.1 Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Application
1.5.2 CNS
1.5.3 Cardiovascular
1.5.4 Genitourinary/Hormonal Drugs
1.5.5 Respiratory
1.5.6 Rheumatology
1.5.7 Diabetes
1.5.8 Oncology
1.5.9 Others
1.6 Coronavirus Disease 2019 (Covid-19): Active Pharmaceutical Ingredients (API) Industry Impact
1.6.1 How the Covid-19 is Affecting the Active Pharmaceutical Ingredients (API) Industry
1.6.1.1 Active Pharmaceutical Ingredients (API) Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Active Pharmaceutical Ingredients (API) Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Active Pharmaceutical Ingredients (API) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Active Pharmaceutical Ingredients (API) Market Size Estimates and Forecasts
2.1.1 Global Active Pharmaceutical Ingredients (API) Revenue 2015-2026
2.1.2 Global Active Pharmaceutical Ingredients (API) Sales 2015-2026
2.2 Active Pharmaceutical Ingredients (API) Market Size by Region: 2020 Versus 2026
2.2.1 Global Active Pharmaceutical Ingredients (API) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Active Pharmaceutical Ingredients (API) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Active Pharmaceutical Ingredients (API) Competitor Landscape by Players
3.1 Active Pharmaceutical Ingredients (API) Sales by Manufacturers
3.1.1 Active Pharmaceutical Ingredients (API) Sales by Manufacturers (2015-2020)
3.1.2 Active Pharmaceutical Ingredients (API) Sales Market Share by Manufacturers (2015-2020)
3.2 Active Pharmaceutical Ingredients (API) Revenue by Manufacturers
3.2.1 Active Pharmaceutical Ingredients (API) Revenue by Manufacturers (2015-2020)
3.2.2 Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Active Pharmaceutical Ingredients (API) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Active Pharmaceutical Ingredients (API) Revenue in 2019
3.2.5 Global Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Active Pharmaceutical Ingredients (API) Price by Manufacturers
3.4 Active Pharmaceutical Ingredients (API) Manufacturing Base Distribution, Product Types
3.4.1 Active Pharmaceutical Ingredients (API) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Active Pharmaceutical Ingredients (API) Product Type
3.4.3 Date of International Manufacturers Enter into Active Pharmaceutical Ingredients (API) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Active Pharmaceutical Ingredients (API) Market Size by Type (2015-2020)
4.1.1 Global Active Pharmaceutical Ingredients (API) Sales by Type (2015-2020)
4.1.2 Global Active Pharmaceutical Ingredients (API) Revenue by Type (2015-2020)
4.1.3 Active Pharmaceutical Ingredients (API) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Active Pharmaceutical Ingredients (API) Market Size Forecast by Type (2021-2026)
4.2.1 Global Active Pharmaceutical Ingredients (API) Sales Forecast by Type (2021-2026)
4.2.2 Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Type (2021-2026)
4.2.3 Active Pharmaceutical Ingredients (API) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Active Pharmaceutical Ingredients (API) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Active Pharmaceutical Ingredients (API) Market Size by Application (2015-2020)
5.1.1 Global Active Pharmaceutical Ingredients (API) Sales by Application (2015-2020)
5.1.2 Global Active Pharmaceutical Ingredients (API) Revenue by Application (2015-2020)
5.1.3 Active Pharmaceutical Ingredients (API) Price by Application (2015-2020)
5.2 Active Pharmaceutical Ingredients (API) Market Size Forecast by Application (2021-2026)
5.2.1 Global Active Pharmaceutical Ingredients (API) Sales Forecast by Application (2021-2026)
5.2.2 Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Application (2021-2026)
5.2.3 Global Active Pharmaceutical Ingredients (API) Price Forecast by Application (2021-2026)
6 North America
6.1 North America Active Pharmaceutical Ingredients (API) by Country
6.1.1 North America Active Pharmaceutical Ingredients (API) Sales by Country
6.1.2 North America Active Pharmaceutical Ingredients (API) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Active Pharmaceutical Ingredients (API) Market Facts & Figures by Type
6.3 North America Active Pharmaceutical Ingredients (API) Market Facts & Figures by Application
7 Europe
7.1 Europe Active Pharmaceutical Ingredients (API) by Country
7.1.1 Europe Active Pharmaceutical Ingredients (API) Sales by Country
7.1.2 Europe Active Pharmaceutical Ingredients (API) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Active Pharmaceutical Ingredients (API) Market Facts & Figures by Type
7.3 Europe Active Pharmaceutical Ingredients (API) Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Active Pharmaceutical Ingredients (API) by Region
8.1.1 Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Region
8.1.2 Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Active Pharmaceutical Ingredients (API) Market Facts & Figures by Type
8.3 Asia Pacific Active Pharmaceutical Ingredients (API) Market Facts & Figures by Application
9 Latin America
9.1 Latin America Active Pharmaceutical Ingredients (API) by Country
9.1.1 Latin America Active Pharmaceutical Ingredients (API) Sales by Country
9.1.2 Latin America Active Pharmaceutical Ingredients (API) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Active Pharmaceutical Ingredients (API) Market Facts & Figures by Type
9.3 Central & South America Active Pharmaceutical Ingredients (API) Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Active Pharmaceutical Ingredients (API) by Country
10.1.1 Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Country
10.1.2 Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Active Pharmaceutical Ingredients (API) Market Facts & Figures by Type
10.3 Middle East and Africa Active Pharmaceutical Ingredients (API) Market Facts & Figures by Application
11 Company Profiles
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Description, Business Overview and Total Revenue
11.1.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Teva Active Pharmaceutical Ingredients (API) Products Offered
11.1.5 Teva Recent Development
11.2 Mylan
11.2.1 Mylan Corporation Information
11.2.2 Mylan Description, Business Overview and Total Revenue
11.2.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Mylan Active Pharmaceutical Ingredients (API) Products Offered
11.2.5 Mylan Recent Development
11.3 DSM
11.3.1 DSM Corporation Information
11.3.2 DSM Description, Business Overview and Total Revenue
11.3.3 DSM Sales, Revenue and Gross Margin (2015-2020)
11.3.4 DSM Active Pharmaceutical Ingredients (API) Products Offered
11.3.5 DSM Recent Development
11.4 Aurobindo Pharma
11.4.1 Aurobindo Pharma Corporation Information
11.4.2 Aurobindo Pharma Description, Business Overview and Total Revenue
11.4.3 Aurobindo Pharma Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Products Offered
11.4.5 Aurobindo Pharma Recent Development
11.5 Aspen
11.5.1 Aspen Corporation Information
11.5.2 Aspen Description, Business Overview and Total Revenue
11.5.3 Aspen Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Aspen Active Pharmaceutical Ingredients (API) Products Offered
11.5.5 Aspen Recent Development
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Description, Business Overview and Total Revenue
11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Novartis Active Pharmaceutical Ingredients (API) Products Offered
11.6.5 Novartis Recent Development
11.7 BASF
11.7.1 BASF Corporation Information
11.7.2 BASF Description, Business Overview and Total Revenue
11.7.3 BASF Sales, Revenue and Gross Margin (2015-2020)
11.7.4 BASF Active Pharmaceutical Ingredients (API) Products Offered
11.7.5 BASF Recent Development
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Description, Business Overview and Total Revenue
11.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Pfizer Active Pharmaceutical Ingredients (API) Products Offered
11.8.5 Pfizer Recent Development
11.9 Huahai Pharmaceutical
11.9.1 Huahai Pharmaceutical Corporation Information
11.9.2 Huahai Pharmaceutical Description, Business Overview and Total Revenue
11.9.3 Huahai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Products Offered
11.9.5 Huahai Pharmaceutical Recent Development
11.10 Hisun Pharmaceutical
11.10.1 Hisun Pharmaceutical Corporation Information
11.10.2 Hisun Pharmaceutical Description, Business Overview and Total Revenue
11.10.3 Hisun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Products Offered
11.10.5 Hisun Pharmaceutical Recent Development
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Description, Business Overview and Total Revenue
11.1.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Teva Active Pharmaceutical Ingredients (API) Products Offered
11.1.5 Teva Recent Development
11.12 Zhejiang Medicine
11.12.1 Zhejiang Medicine Corporation Information
11.12.2 Zhejiang Medicine Description, Business Overview and Total Revenue
11.12.3 Zhejiang Medicine Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Zhejiang Medicine Products Offered
11.12.5 Zhejiang Medicine Recent Development
11.13 Dr. Reddy's Laboratories
11.13.1 Dr. Reddy's Laboratories Corporation Information
11.13.2 Dr. Reddy's Laboratories Description, Business Overview and Total Revenue
11.13.3 Dr. Reddy's Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Dr. Reddy's Laboratories Products Offered
11.13.5 Dr. Reddy's Laboratories Recent Development
11.14 Zhejiang NHU
11.14.1 Zhejiang NHU Corporation Information
11.14.2 Zhejiang NHU Description, Business Overview and Total Revenue
11.14.3 Zhejiang NHU Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Zhejiang NHU Products Offered
11.14.5 Zhejiang NHU Recent Development
11.15 Bayer
11.15.1 Bayer Corporation Information
11.15.2 Bayer Description, Business Overview and Total Revenue
11.15.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Bayer Products Offered
11.15.5 Bayer Recent Development
11.16 NCPC
11.16.1 NCPC Corporation Information
11.16.2 NCPC Description, Business Overview and Total Revenue
11.16.3 NCPC Sales, Revenue and Gross Margin (2015-2020)
11.16.4 NCPC Products Offered
11.16.5 NCPC Recent Development
11.17 AbbVie
11.17.1 AbbVie Corporation Information
11.17.2 AbbVie Description, Business Overview and Total Revenue
11.17.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.17.4 AbbVie Products Offered
11.17.5 AbbVie Recent Development
11.18 Shandong Xinhua Pharmaceutical
11.18.1 Shandong Xinhua Pharmaceutical Corporation Information
11.18.2 Shandong Xinhua Pharmaceutical Description, Business Overview and Total Revenue
11.18.3 Shandong Xinhua Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Shandong Xinhua Pharmaceutical Products Offered
11.18.5 Shandong Xinhua Pharmaceutical Recent Development
11.19 Northeast Pharm
11.19.1 Northeast Pharm Corporation Information
11.19.2 Northeast Pharm Description, Business Overview and Total Revenue
11.19.3 Northeast Pharm Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Northeast Pharm Products Offered
11.19.5 Northeast Pharm Recent Development
11.20 Harbin Pharmaceutical
11.20.1 Harbin Pharmaceutical Corporation Information
11.20.2 Harbin Pharmaceutical Description, Business Overview and Total Revenue
11.20.3 Harbin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Harbin Pharmaceutical Products Offered
11.20.5 Harbin Pharmaceutical Recent Development
11.21 LKPC
11.21.1 LKPC Corporation Information
11.21.2 LKPC Description, Business Overview and Total Revenue
11.21.3 LKPC Sales, Revenue and Gross Margin (2015-2020)
11.21.4 LKPC Products Offered
11.21.5 LKPC Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Active Pharmaceutical Ingredients (API) Market Estimates and Projections by Region
12.1.1 Global Active Pharmaceutical Ingredients (API) Sales Forecast by Regions 2021-2026
12.1.2 Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Regions 2021-2026
12.2 North America Active Pharmaceutical Ingredients (API) Market Size Forecast (2021-2026)
12.2.1 North America: Active Pharmaceutical Ingredients (API) Sales Forecast (2021-2026)
12.2.2 North America: Active Pharmaceutical Ingredients (API) Revenue Forecast (2021-2026)
12.2.3 North America: Active Pharmaceutical Ingredients (API) Market Size Forecast by Country (2021-2026)
12.3 Europe Active Pharmaceutical Ingredients (API) Market Size Forecast (2021-2026)
12.3.1 Europe: Active Pharmaceutical Ingredients (API) Sales Forecast (2021-2026)
12.3.2 Europe: Active Pharmaceutical Ingredients (API) Revenue Forecast (2021-2026)
12.3.3 Europe: Active Pharmaceutical Ingredients (API) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Active Pharmaceutical Ingredients (API) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Active Pharmaceutical Ingredients (API) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Active Pharmaceutical Ingredients (API) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Active Pharmaceutical Ingredients (API) Market Size Forecast by Region (2021-2026)
12.5 Latin America Active Pharmaceutical Ingredients (API) Market Size Forecast (2021-2026)
12.5.1 Latin America: Active Pharmaceutical Ingredients (API) Sales Forecast (2021-2026)
12.5.2 Latin America: Active Pharmaceutical Ingredients (API) Revenue Forecast (2021-2026)
12.5.3 Latin America: Active Pharmaceutical Ingredients (API) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Active Pharmaceutical Ingredients (API) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Active Pharmaceutical Ingredients (API) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Active Pharmaceutical Ingredients (API) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Active Pharmaceutical Ingredients (API) Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Active Pharmaceutical Ingredients (API) Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Active Pharmaceutical Ingredients (API) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Active Pharmaceutical Ingredients (API) Market Segments
Table 2. Ranking of Global Top Active Pharmaceutical Ingredients (API) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Synthetic APIs
Table 5. Major Manufacturers of Biotech APIs
Table 6. COVID-19 Impact Global Market: (Four Active Pharmaceutical Ingredients (API) Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Active Pharmaceutical Ingredients (API) Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Active Pharmaceutical Ingredients (API) Players to Combat Covid-19 Impact
Table 11. Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Active Pharmaceutical Ingredients (API) Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Active Pharmaceutical Ingredients (API) Sales by Regions 2015-2020 (K MT)
Table 14. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Regions (2015-2020)
Table 15. Global Active Pharmaceutical Ingredients (API) Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Active Pharmaceutical Ingredients (API) Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Active Pharmaceutical Ingredients (API) Sales Share by Manufacturers (2015-2020)
Table 18. Global Active Pharmaceutical Ingredients (API) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Active Pharmaceutical Ingredients (API) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Active Pharmaceutical Ingredients (API) as of 2019)
Table 20. Active Pharmaceutical Ingredients (API) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Active Pharmaceutical Ingredients (API) Price (2015-2020) (USD/MT)
Table 23. Active Pharmaceutical Ingredients (API) Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Active Pharmaceutical Ingredients (API) Product Type
Table 25. Date of International Manufacturers Enter into Active Pharmaceutical Ingredients (API) Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Active Pharmaceutical Ingredients (API) Sales by Type (2015-2020) (K MT)
Table 28. Global Active Pharmaceutical Ingredients (API) Sales Share by Type (2015-2020)
Table 29. Global Active Pharmaceutical Ingredients (API) Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Active Pharmaceutical Ingredients (API) Revenue Share by Type (2015-2020)
Table 31. Active Pharmaceutical Ingredients (API) Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Active Pharmaceutical Ingredients (API) Sales by Application (2015-2020) (K MT)
Table 33. Global Active Pharmaceutical Ingredients (API) Sales Share by Application (2015-2020)
Table 34. North America Active Pharmaceutical Ingredients (API) Sales by Country (2015-2020) (K MT)
Table 35. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2015-2020)
Table 36. North America Active Pharmaceutical Ingredients (API) Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2015-2020)
Table 38. North America Active Pharmaceutical Ingredients (API) Sales by Type (2015-2020) (K MT)
Table 39. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)
Table 40. North America Active Pharmaceutical Ingredients (API) Sales by Application (2015-2020) (K MT)
Table 41. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)
Table 42. Europe Active Pharmaceutical Ingredients (API) Sales by Country (2015-2020) (K MT)
Table 43. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2015-2020)
Table 44. Europe Active Pharmaceutical Ingredients (API) Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2015-2020)
Table 46. Europe Active Pharmaceutical Ingredients (API) Sales by Type (2015-2020) (K MT)
Table 47. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)
Table 48. Europe Active Pharmaceutical Ingredients (API) Sales by Application (2015-2020) (K MT)
Table 49. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)
Table 58. Latin America Active Pharmaceutical Ingredients (API) Sales by Country (2015-2020) (K MT)
Table 59. Latin America Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Active Pharmaceutical Ingredients (API) Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2015-2020)
Table 62. Latin America Active Pharmaceutical Ingredients (API) Sales by Type (2015-2020) (K MT)
Table 63. Latin America Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)
Table 64. Latin America Active Pharmaceutical Ingredients (API) Sales by Application (2015-2020) (K MT)
Table 65. Latin America Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2015-2020)
Table 74. Teva Corporation Information
Table 75. Teva Description and Major Businesses
Table 76. Teva Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Teva Product
Table 78. Teva Recent Development
Table 79. Mylan Corporation Information
Table 80. Mylan Description and Major Businesses
Table 81. Mylan Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Mylan Product
Table 83. Mylan Recent Development
Table 84. DSM Corporation Information
Table 85. DSM Description and Major Businesses
Table 86. DSM Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. DSM Product
Table 88. DSM Recent Development
Table 89. Aurobindo Pharma Corporation Information
Table 90. Aurobindo Pharma Description and Major Businesses
Table 91. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Aurobindo Pharma Product
Table 93. Aurobindo Pharma Recent Development
Table 94. Aspen Corporation Information
Table 95. Aspen Description and Major Businesses
Table 96. Aspen Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Aspen Product
Table 98. Aspen Recent Development
Table 99. Novartis Corporation Information
Table 100. Novartis Description and Major Businesses
Table 101. Novartis Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Novartis Product
Table 103. Novartis Recent Development
Table 104. BASF Corporation Information
Table 105. BASF Description and Major Businesses
Table 106. BASF Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. BASF Product
Table 108. BASF Recent Development
Table 109. Pfizer Corporation Information
Table 110. Pfizer Description and Major Businesses
Table 111. Pfizer Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Pfizer Product
Table 113. Pfizer Recent Development
Table 114. Huahai Pharmaceutical Corporation Information
Table 115. Huahai Pharmaceutical Description and Major Businesses
Table 116. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Huahai Pharmaceutical Product
Table 118. Huahai Pharmaceutical Recent Development
Table 119. Hisun Pharmaceutical Corporation Information
Table 120. Hisun Pharmaceutical Description and Major Businesses
Table 121. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Hisun Pharmaceutical Product
Table 123. Hisun Pharmaceutical Recent Development
Table 124. Sun Pharmaceutical Industries Corporation Information
Table 125. Sun Pharmaceutical Industries Description and Major Businesses
Table 126. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. Sun Pharmaceutical Industries Product
Table 128. Sun Pharmaceutical Industries Recent Development
Table 129. Zhejiang Medicine Corporation Information
Table 130. Zhejiang Medicine Description and Major Businesses
Table 131. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. Zhejiang Medicine Product
Table 133. Zhejiang Medicine Recent Development
Table 134. Dr. Reddy's Laboratories Corporation Information
Table 135. Dr. Reddy's Laboratories Description and Major Businesses
Table 136. Dr. Reddy's Laboratories Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 137. Dr. Reddy's Laboratories Product
Table 138. Dr. Reddy's Laboratories Recent Development
Table 139. Zhejiang NHU Corporation Information
Table 140. Zhejiang NHU Description and Major Businesses
Table 141. Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 142. Zhejiang NHU Product
Table 143. Zhejiang NHU Recent Development
Table 144. Bayer Corporation Information
Table 145. Bayer Description and Major Businesses
Table 146. Bayer Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 147. Bayer Product
Table 148. Bayer Recent Development
Table 149. NCPC Corporation Information
Table 150. NCPC Description and Major Businesses
Table 151. NCPC Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 152. NCPC Product
Table 153. NCPC Recent Development
Table 154. AbbVie Corporation Information
Table 155. AbbVie Description and Major Businesses
Table 156. AbbVie Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 157. AbbVie Product
Table 158. AbbVie Recent Development
Table 159. Shandong Xinhua Pharmaceutical Corporation Information
Table 160. Shandong Xinhua Pharmaceutical Description and Major Businesses
Table 161. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 162. Shandong Xinhua Pharmaceutical Product
Table 163. Shandong Xinhua Pharmaceutical Recent Development
Table 164. Northeast Pharm Corporation Information
Table 165. Northeast Pharm Description and Major Businesses
Table 166. Northeast Pharm Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 167. Northeast Pharm Product
Table 168. Northeast Pharm Recent Development
Table 169. Harbin Pharmaceutical Corporation Information
Table 170. Harbin Pharmaceutical Description and Major Businesses
Table 171. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 172. Harbin Pharmaceutical Product
Table 173. Harbin Pharmaceutical Recent Development
Table 174. LKPC Corporation Information
Table 175. LKPC Description and Major Businesses
Table 176. LKPC Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 177. LKPC Product
Table 178. LKPC Recent Development
Table 179. Global Active Pharmaceutical Ingredients (API) Sales Forecast by Regions (2021-2026) (K MT)
Table 180. Global Active Pharmaceutical Ingredients (API) Sales Market Share Forecast by Regions (2021-2026)
Table 181. Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 182. Global Active Pharmaceutical Ingredients (API) Revenue Market Share Forecast by Regions (2021-2026)
Table 183. North America: Active Pharmaceutical Ingredients (API) Sales Forecast by Country (2021-2026) (K MT)
Table 184. North America: Active Pharmaceutical Ingredients (API) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 185. Europe: Active Pharmaceutical Ingredients (API) Sales Forecast by Country (2021-2026) (K MT)
Table 186. Europe: Active Pharmaceutical Ingredients (API) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 187. Asia Pacific: Active Pharmaceutical Ingredients (API) Sales Forecast by Region (2021-2026) (K MT)
Table 188. Asia Pacific: Active Pharmaceutical Ingredients (API) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 189. Latin America: Active Pharmaceutical Ingredients (API) Sales Forecast by Country (2021-2026) (K MT)
Table 190. Latin America: Active Pharmaceutical Ingredients (API) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 191. Middle East and Africa: Active Pharmaceutical Ingredients (API) Sales Forecast by Country (2021-2026) (K MT)
Table 192. Middle East and Africa: Active Pharmaceutical Ingredients (API) Revenue Forecast by Country (2021-2026) (US$ Million)
T
  • Dextran - Global Market Insights and Sales Trends 2024 -2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 122
    The global Dextran market was valued at US$ 234.14 million in 2022 and it will reach US$ 346.64 million by the end of 2029, growing at a CAGR of 5.97% during 2023-2029. Report Scope This report aims to provide a comprehensive presentation of the global market for Dextran, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed bu......
  • Global Corticosteroids API Market Research Report 2023
    Published: 11-Jan-2024        Price: US 2900 Onwards        Pages: 162
    The global Corticosteroids API market was valued at US$ 2206.26 million in 2022 and is anticipated to reach US$ 3309.40 million by 2029, witnessing a CAGR of 6.11% during the forecast period 2023-2029. North American market for Corticosteroids API is estimated to increase from $ 220.53 million in 2022 to reach $ 302.18 million by 2029, at a CAGR of 4.69 % during the forecast period of 2023 through 2029. Europe market for Corticosteroids API is estimated to increase from $ 512.79 mi......
  • Global HPLC Columns Market Research Report 2023
    Published: 11-Jan-2024        Price: US 2900 Onwards        Pages: 149
    The global HPLC Columns market was valued at US$ 1823.16 million in 2022 and is anticipated to reach US$ 2674.78 million by 2029, witnessing a CAGR of 6.37% during the forecast period 2023-2029. The major global manufacturers of HPLC Columns include Agilent, Waters Corporation, Shimadzu, Thermo Fisher Scientific, Danaher, Hamilton, Merck, Bio - Rad, and Restek, etc. In 2022, the world's top three vendors accounted for approximately 48.41 % of the revenue. Report Scope This r......
  • Global Inorganic Advanced Phase Change Materials Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Inorganic Advanced Phase Change Materials market was valued at US$ 960.3 million in 2023 and is anticipated to reach US$ 2087.3 million by 2030, witnessing a CAGR of 11.9% during The forecast period 2024-2030. North American market for Inorganic Advanced Phase Change Materials is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Inorganic Advanced Phase Ch......
  • Global Material Jetting 3D Printing Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 88
    The global Material Jetting 3D Printing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Material Jetting 3D Printing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Material Jetting 3D Printing is estimated to increase from $ million i......
  • Global Halogen Free Material Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 81
    The global Halogen Free Material market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Halogen Free Material is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Halogen Free Material is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Silicone Adhesives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 101
    The global Silicone Adhesives market was valued at US$ 1999.8 million in 2023 and is anticipated to reach US$ 2628.8 million by 2030, witnessing a CAGR of 3.5% during The forecast period 2024-2030. North American market for Silicone Adhesives is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Silicone Adhesives is estimated to increase from $ million in 2023 to rea......
  • Global Paraffin Hydrotreating Catalyst Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 91
    The global Paraffin Hydrotreating Catalyst market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Paraffin Hydrotreating Catalyst is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Paraffin Hydrotreating Catalyst is estimated to increase from $ ......
  • Global Stained Glass Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Stained Glass market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Stained Glass is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Stained Glass is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs